While AKT activates the mTOR pathway, AMPK inhibits it, suggesting that metformin’s activation of AMPK can suppress abnormal cell proliferation, which is relevant in both diabetes management and cancer prevention [11,25]. The gene discussed is AKT1; the disease is cancer.